分析年龄特异的万科米辛不良事件:基于FAERS数据库的现实世界药监测研究
International journal of surgery (London, England)
|December 17, 2025
概括
范科米辛的安全性概况因年龄而异,在儿童,成人和老年人中观察到明显的不良事件. 这项现实世界的药监测研究发现了新的安全信号,增强了对万科米的理解.
科学领域:
- 药监和药物安全 药监和药物安全
- 临床药理学中的真实世界证据 (RWE)
- 药物不良事件 (ADE) 分析
背景情况:
- 范科米辛是一种关键的抗生素,但其安全性需要持续监测.
- 了解特定于年龄的不良药物事件 (ADE) 模式对于优化万科米辛治疗至关重要.
- 现实世界的药监数据为超越临床试验的药物安全提供了宝贵的见解.
研究的目的:
- 描述与万科米相关的特定年龄的不良药物事件 (ADE) 概况.
- 利用现实世界的药监数据来进一步了解万科米辛的安全性.
- 识别新的安全信号,并在不同年龄层进行比较.
主要方法:
- 使用了食品和药物管理局的不良事件报告系统 (FAERS) 数据库.
- 从2019年第一季度到2024年第三季度收集的数据,重点关注万科米辛作为首要疑似药物.
- 采用不成比例性分析,按年龄组分层研究人群 (0-17,18-44,45-64,≥65岁).
主要成果:
- 分析了8379份与万科素相关的ADE报告,所有年龄组均有显著的代表性.
- 确定了不同的ADE模式:儿童的电解质障碍,成人的皮肤疾病和老年人的感染.
- 每个年龄组检测到独特的高风险信号,包括"血液电解质异常" (0-17岁),"脊髓中风" (18-44岁),"骨髓成熟停止" (45-64岁) 和"出血性闭合性视网膜血管炎" (≥65岁).
- 发现了32种新的不良事件,主要影响心脏和神经系统,并未列入当前的万科米辛标签.
结论:
- 对FAERS数据的年龄分层分析揭示了与化相关的ADE信号的显著差异.
- 该研究证实了已知的万科米辛风险,并确定了新的安全问题,扩大了其安全性.
- 结果提供了基于证据的指导,用于优化临床米素使用和风险管理策略.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
217
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
217
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
208
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
208
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
215
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
215
01:15Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209